Research priorities in biomarkers and surrogate end-points.
Ideal tests of the effects of therapeutic interventions measure the desired outcomes; however, the desired outcomes are not always easily measured or may be long-term objectives. Biomarkers and surrogate end-points are often cheaper and easier to measure and can be measured over a shorter time span....
| Main Author: | |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2012
|